Qure.ai to Debut Multimodality AI Platform for Lung Cancer Imaging at ASCO 2024
In addition to detecting missed lung nodules on X-rays, the AI-powered Qure.ai lung cancer continuum platform reportedly automates lung nodule measurement on CT scans and facilitates multimodality reporting.
Offering multimodality potential in detecting, monitoring, and reporting of lung cancer, Qure.ai will introduce an artificial intelligence (AI)-enabled lung cancer continuum platform at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
Key attributes of the lung cancer continuum platform include AI-enabled lung nodule measurement and tracking of volumetric growth of disease, according to Qure.ai, the developer of the platform. The company said the lung cancer continuum platform enables monitoring of drug efficacy, provides triage prioritization, and facilitates multimodality reporting.
Key attributes of the Qure. ai lung cancer continuum platform, slated to debut at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, include AI-enabled lung nodule detection, measurement and tracking of volumetric growth of lung disease, according to Qure.ai, the developer of the platform. (Image courtesy of Qure.ai.)
Qure.ai also emphasized the capability of the lung cancer continuum platform to improve early detection of lung cancer through detection of lung nodules missed on X-rays.
“Artificial intelligence for lung cancer powers early detection, not just as part of existing screening programs, but by finding small pulmonary nodules, often opportunistically, during general health-care imaging procedures,” noted Prashant Warier, the CEO and co-founder of Qure.ai. “This enables earlier identification and referral for imaging or treatment pathways. It also helps overcome the ongoing challenges of low lung cancer screening appointment uptake rates.”
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
